Involvement of free oxygen radicals in beta-amyloidosis: an hypothesis.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Neurobiology of Aging

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 7969721
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Re-examination of ex-boxers' brains using immunohistochemistry with antibodies to amyloid β-protein and tau protein

  2004cited by this paper
• Ferritin is a component of the neuritic (senile) plaque in Alzheimer dementia

  2004cited by this paper
• A histochemical study of iron, transferrin, and ferritin in Alzheimer's diseased brains

  1992cited by this paper
• Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14.

  1992cited by this paper
• The ability of (-)deprenyl to increase superoxide dismutase activities in the rat is tissue and brain region selective.

  1992cited by this paper
• (–)Deprenyl‐Medication: A Strategy To Modulate the Age‐Related Decline of the Striatal Dopaminergic System

  1992cited by this paper
• Changes in intraneuronal lipopigment in Alzheimer's disease.

  1992cited by this paper
• Immunohistochemical evidence of oxidative [corrected] stress in Alzheimer's disease.

  1992cited by this paper
• The pharmacological profile of (-)deprenyl (selegiline) and its relevance for humans: a personal view.

  1992cited by this paper
• Preliminary characterization of long-term reaggregating cultures of trisomy 16 central nervous system.

  1992cited by this paper
• Amyloidogenicity of beta A4 and beta A4-bearing amyloid protein precursor fragments by metal-catalyzed oxidation.

  1992cited by this paper
• CBF and cognitive evaluation of Alzheimer type patients before and after IMAO-B treatment: a pilot study.

  1992cited by this paper
• Degeneration in vitro of post-mitotic neurons overexpressing the Alzheimer amyloid protein precursor

  1992cited by this paper
• Amyloid beta-peptide is produced by cultured cells during normal metabolism.

  1992cited by this paper
• The seminal role of beta-amyloid in the pathogenesis of Alzheimer disease.

  1992cited by this paper
• Elicitor- and wound-induced oxidative cross-linking of a proline-rich plant cell wall protein: a novel, rapid defense response.

  1992cited by this paper
• Production of the Alzheimer amyloid beta protein by normal proteolytic processing.

  1992cited by this paper
• Targeting of cell-surface β-amyloid precursor protein to lysosomes: alternative processing into amyloid-bearing fragments

  1992cited by this paper
• Mouse model of neurodegeneration: atrophy of basal forebrain cholinergic neurons in trisomy 16 transplants.

  1992cited by this paper
• Enhanced hydroxyl radical generation by 2′‐methyl analog of MPTP: Suppression by clorgyline and deprenyl

  1992cited by this paper
• Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids

  1992cited by this paper
• Processing of the amyloid protein precursor to potentially amyloidogenic derivatives.

  1992cited by this paper
• Deprenyl effects on levodopa pharmacodynamics, mood, and free radical scavenging

  1992cited by this paper
• Solvent effects on beta protein toxicity in vivo.

  1992cited by this paper
• Vitamin E protects nerve cells from amyloid beta protein toxicity.

  1992cited by this paper
• A population-based investigation of Parkinson's disease with and without dementia. Relationship to age and gender.

  1992cited by this paper
• beta-Amyloid neurotoxicity: a discussion of in vitro findings.

  1992cited by this paper
• Brain transplants of cells expressing the carboxyl-terminal fragment of the Alzheimer amyloid protein precursor cause specific neuropathology in vivo.

  1992cited by this paper
• Oxygen free radicals and Parkinson's disease.

  1991cited by this paper
• Intramuscular desferrioxamine in patients with Alzheimer's disease.

  1991cited by this paper
• The 717Val----Ile substitution in amyloid precursor protein is associated with familial Alzheimer's disease regardless of ethnic groups.

  1991cited by this paper
• Risk of dementia in first-degree relatives of patients with Alzheimer's disease and related disorders.

  1991cited by this paper
• beta A4 amyloid protein deposition in brain after head trauma.

  1991cited by this paper
• Dementia in cancer patients undergoing chemotherapy: implication of free radical injury and relevance to Alzheimer disease.

  1991cited by this paper
• Clinical risk factors for Alzheimer's disease

  1991cited by this paper
• Mis-sense mutation Val----Ile in exon 17 of amyloid precursor protein gene in Japanese familial Alzheimer's disease.

  1991cited by this paper
• Iron in brain function and dysfunction with emphasis on Parkinson's disease.

  1991cited by this paper
• Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease

  1991cited by this paper
• Alzheimer's mutation

  1991cited by this paper
• L-deprenyl therapy improves verbal memory in amnesic Alzheimer patients.

  1991cited by this paper
• Lysosomal hydrolases of different classes are abnormally distributed in brains of patients with Alzheimer disease.

  1991cited by this paper
• Transplants of mouse trisomy 16 hippocampus provide a model of Alzheimer's disease neuropathology.

  1991cited by this paper
• A Pilot Study of Low-Dose L-Deprenyl in Alzheimer's Disease

  1991cited by this paper
• Effects of injected Alzheimer beta-amyloid cores in rat brain.

  1991cited by this paper
• Dementing Disease in a Married Couple

  1991cited by this paper
• Linkage studies in familial Alzheimer disease: evidence for chromosome 19 linkage.

  1991cited by this paper
• An in vivo model for the neurodegenerative effects of beta amyloid and protection by substance P.

  1991cited by this paper
• Advances in Alzheimer's disease

  1991cited by this paper
• Sensitive enzyme immunoassay for human Mn superoxide dismutase.

  1990cited by this paper
• Genetic linkage studies suggest that Alzheimer's disease is not a single homogeneous disorder

  1990cited by this paper
• Formation of amyloid-like fibrils in COS cells overexpressing part of the Alzheimer amyloid protein precursor

  1990cited by this paper
• Prevalence of clinically diagnosed Alzheimer's disease and other dementing disorders

  1990cited by this paper
• The association between aluminum-containing products and Alzheimer's disease.

  1990cited by this paper
• Mixed solvent exposure and cerebral symptoms among active and retired workers. An epidemiological investigation of 3387 men aged 53–75 years

  1990cited by this paper
• The occult aftermath of boxing.

  1990cited by this paper
• The association between head trauma and Alzheimer's disease.

  1990cited by this paper
• Women, myocardial infarction, and dementia in the very old

  1990cited by this paper
• Dementing disease in a married couple.

  1990cited by this paper
• An estimate of the incidence of dementia in idiopathic Parkinson's disease

  1990cited by this paper
• The Gospel Oak Study: prevalence rates of dementia, depression and activity limitation among elderly residents in Inner London

  1990cited by this paper
• Cleavage of amyloid beta peptide during constitutive processing of its precursor.

  1990cited by this paper
• Neuropsychological effects of L-deprenyl in Alzheimer's type dementia.

  1990cited by this paper
• Autopsy Samples of Alzheimer's Cortex Show Increased Peroxidation In Vitro

  1990cited by this paper
• Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides.

  1990cited by this paper
• The prevalence of dementia and Alzheimer's disease in Shanghai, China: Impact of age, gender, and education

  1990cited by this paper
• A case‐control study of Alzheimer's disease in Australia

  1990cited by this paper
• Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type.

  1990cited by this paper
• Alzheimer Disease and the Dementia of Parkinson Disease: Comparative Investigations

  1990cited by this paper
• Down patients: extracellular preamyloid deposits precede neuritic degeneration and senile plaques.

  1989cited by this paper
• Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease.

  1989cited by this paper
• Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported.

  1989cited by this paper
• Immunoreactivity of neuronal lipofuscin with monoclonal antibodies to the amyloid beta-protein.

  1989cited by this paper
• Superoxide dismutase activity in Alzheimer's disease: possible mechanism for paired helical filament formation.

  1989cited by this paper
• Geographical relation between Alzheimer's disease and aluminum in drinking water.

  1989cited by this paper
• History of dementia and Parkinson's disease in 1st‐degree relatives of patients with Alzheimer's disease

  1989cited by this paper
• Severe Head Injury Hastens Age of Onset of Alzheimer's Disease

  1989cited by this paper
• Neuronal Lipopigment: A Marker for Cognitive Impairment and Long-Term Effects of Psychotropic Drugs

  1989cited by this paper
• Lipid peroxidation and free radical scavengers in Alzheimer's disease.

  1989cited by this paper
• Development of dementing illnesses in an 80‐year‐old volunteer cohort

  1989cited by this paper
• Lipofuscin as an indicator of oxidative stress and aging.

  1989cited by this paper
• Immunoreactivity of ceroid lipofuscin storage pigment in Batten disease with monoclonal antibodies to the amyloid beta-protein.

  1989cited by this paper
• Oxidants and the central nervous system: some fundamental questions. Is oxidant damage relevant to Parkinson's disease, Alzheimer's disease, traumatic injury or stroke?

  1989cited by this paper
• Alzheimer's disease: a pathogenic role for aluminosilicate-induced phagocytic free radicals.

  1989cited by this paper
• A prospective study of Alzheimer disease in Down syndrome.

  1989cited by this paper
• [Prevalence and incidence of dementia diseases in the elderly population. Results of a population-related longitudinal study in Mannheim].

  1989cited by this paper
• The risk factors for Alzheimer's disease: a review and a hypothesis

  1988cited by this paper
• Preamyloid deposits in the cerebral cortex of patients with Alzheimer's disease and nondemented individuals.

  1988cited by this paper
• A4 amyloid protein deposition and the diagnosis of Alzheimer's disease

  1988cited by this paper
• Trends in incidence of dementing illness in Rochester, Minnesota, in three quinquennial periods, 1960–1974

  1988cited by this paper
• Iron in the brain: implications for Parkinson's and Alzheimer's diseases.

  1988cited by this paper
• The promoter of Alzheimer's disease amyloid A4 precursor gene.

  1988cited by this paper
• Protein damage and degradation by oxygen radicals. III. Modification of secondary and tertiary structure.

  1987cited by this paper
• Risk factors for Alzheimer's disease

  1987cited by this paper
• Amyloid beta protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus.

  1987cited by this paper
• Protein damage and degradation by oxygen radicals. I. general aspects.

  1987cited by this paper
• A case‐control study of smoking habits, dementia, and other illnesses in idiopathic Parkinson's disease

  1987cited by this paper
• Protein damage and degradation by oxygen radicals. IV. Degradation of denatured protein.

  1987cited by this paper
• Head trauma and age of onset of dementia of the Alzheimer type.

  1987cited by this paper
• Case‐control study of late onset “probable Alzheimer's disease”

  1987cited by this paper
• Diagnosis of dementia in cancer patients. Cognitive impairment in these patients can go unrecognized.

  1987cited by this paper

• diAcCA, a Pro-Drug for Carnosic Acid That Activates the Nrf2 Transcriptional Pathway, Shows Efficacy in the 5xFAD Transgenic Mouse Model of Alzheimer’s Disease

  2025cites this paper
• Indian Medicinal Herbs and Formulations for Alzheimer’s Disease, from Traditional Knowledge to Scientific Assessment

  2020cites this paper
• Liposome delivery systems for the treatment of Alzheimer’s disease

  2018cites this paper
• Germinated brown rice and bioactive rich fractions: on going journey from R&D to commercialisation

  2016cites this paper
• Therapeutic advantage of pro-electrophilic drugs to activate the Nrf2/ARE pathway in Alzheimer's disease models

  2016cites this paper
• Oxidative Stress in Alzheimer’s Disease: Should We Keep Trying Antioxidant Therapies?

  2015cites this paper
• The senescence accelerated mouse (SAMP8) as a model for oxidative stress and Alzheimer's disease.

  2012cites this paper
• Evaluating potential of curcumin loaded solid lipid nanoparticles in aluminium induced behavioural, biochemical and histopathological alterations in mice brain.

  2011cites this paper
• Free radicals and low-level photon emission in human pathogenesis: state of the art.

  2008cites this paper
• Beneficial effect of Toona sinensis Roemor on improving cognitive performance and brain degeneration in senescence-accelerated mice

  2006cites this paper
• In vivo protective effects of ferulic acid ethyl ester against amyloid‐beta peptide 1–42‐induced oxidative stress

  2006cites this paper
• Aging‐related increase in oxidative stress correlates with developmental pattern of beta‐secretase activity and beta‐amyloid plaque formation in transgenic Tg2576 mice with Alzheimer‐like pathology

  2004cites this paper
• Role of oxidative stress in neurodegeneration: recent developments in assay methods for oxidative stress and nutraceutical antioxidants.

  2004cites this paper
• Attenuation of chronic neuroinflammation by a nitric oxide‐releasing derivative of the antioxidant ferulic acid

  2004cites this paper
• OHctG Levels in Brain Do Not Indicate Oxidative DNA Damage in Alzheimer ' s Disease

  2003cites this paper
• What can rodent models tell us about cognitive decline in alzheimer’s disease?

  2003cites this paper
• [Treatment of Alzheimer's disease].

  2002cites this paper
• Ginkgo biloba: A Cognitive Enhancer?

  2002cites this paper
• Ammonia and Alzheimer's disease.

  2002cites this paper
• Ibuprofen effects on Alzheimer pathology and open field activity in APPsw transgenic mice.

  2001cites this paper
• Intracellular mechanisms of amyloid accumulation and pathogenesis in Alzheimer’s disease

  2001cites this paper
• The Curry Spice Curcumin Reduces Oxidative Damage and Amyloid Pathology in an Alzheimer Transgenic Mouse

  2001cites this paper
• Effects of free radicals and amyloid beta protein on the currents of expressed rat receptors in Xenopus oocytes.

  2001cites this paper
• Long-term estrogen replacement is associated with improved nonverbal memory and attentional measures in postmenopausal women.

  2001cites this paper
• Neuroimaging of aging and estrogen effects on central nervous system physiology.

  2001cites this paper
• Phenolic anti-inflammatory antioxidant reversal of Abeta-induced cognitive deficits and neuropathology.

  2001cites this paper
• The brain in Down syndrome.

  2001cites this paper
• Inflammation and the pathophysiology of Alzheimer's disease

  2000cites this paper
• Increased mitochondrial superoxide generation in neurons from trisomy 16 mice: a model of Down's syndrome.

  2000cites this paper
• Age-related changes of DNA repair and mitochondrial DNA synthesis in the mouse brain

  1999cites this paper
• Alzheimer's disease and oxidative stress: implications for novel therapeutic approaches.

  1999cites this paper
• Hydroxylamine attenuates the effects of simulated subarachnoid hemorrhage in the rat brain and improves neurological outcome.

  1999cites this paper
• Glutathione depletion exacerbates impairment by oxidative stress of phosphoinositide hydrolysis, AP-1, and NF-kappaB activation by cholinergic stimulation.

  1998cites this paper
• Mechanisms of resistance to oxidative stress in Alzheimer's disease

  1998cites this paper
• Oxidative Damage to Proteins, Lipids, and DNA in Cortical Brain Regions from Patients with Dementia with Lewy Bodies

  1998cites this paper
• Temporal relations among amyloid β-peptide-induced free-radical oxidative stress, neuronal toxicity, and neuronal defensive responses

  1998cites this paper
• Low plasma vitamin C in Alzheimer patients despite an adequate diet

  1998cites this paper
• The involvement of the ubiquitin system in Alzheimer's disease (review).

  1998cites this paper
• [Oxidative stress in the pathogenesis of Alzheimer's disease and antioxidant neuroprotection].

  1998cites this paper
• Endothelial cell dysfunction in response to intracellular overexpression of amyloid precursor protein

  1998cites this paper
• A 12-month, randomized, placebo-controlled trial of propentofylline (HWA 285) in patients with dementia according to DSM III-R. The European Propentofylline Study Group.

  1997cites this paper
• DNA Damage Distribution in the Human Brain as Shown by In Situ End Labeling; Area‐specific Differences in Aging and Alzheimer Disease in the Absence of Apoptotic Morphology

  1997cites this paper
• Evidence against increased glycoxidation in patients with Alzheimer's disease.

  1997cites this paper
• An Assessment of Oxidative Damage to Proteins, Lipids, and DNA in Brain from Patients with Alzheimer's Disease

  1997cites this paper
• Zinc and Alzheimer's disease: is there a direct link?

  1997cites this paper
• Dexamethasone attenuates NF-kappa B DNA binding activity without inducing I kappa B levels in rat brain in vivo.

  1997cites this paper
• Oxidative modification of glutamine synthetase by amyloid beta peptide.

  1997cites this paper
• Salen-manganese complexes: combined superoxide dismutase/catalase mimics with broad pharmacological efficacy.

  1997cites this paper
• The search for disease-modifying treatment for Alzheimer's disease

  1997cites this paper
• Amyloid beta-protein toxicity and oxidative stress in Alzheimer's disease.

  1997cites this paper
• Effects of anapsos on the activity of the enzyme Cu-Zn-superoxide dismutase in an animal model of neuronal degeneration.

  1997cites this paper
• Pathophysiological aspects of human neurodegenerative diseases.

  1997cites this paper
• HWA 285 (Propentofylline)—A New Compound for the Treatment of Both Vascular Dementia and Dementia of the Alzheimer Type

  1996cites this paper
• beta-Amyloid toxicity in organotypic hippocampal cultures: protection by EUK-8, a synthetic catalytic free radical scavenger.

  1996cites this paper
• Evidence against the involvement of reactive oxygen species in the pathogenesis of neuronal death in Down's syndrome and Alzheimer's disease.

  1996cites this paper
• Increased regional brain concentrations of ceruloplasmin in neurodegenerative disorders.

  1996cites this paper
• Deleterious network hypothesis of Alzheimer's disease.

  1996cites this paper
• Immunocytochemical localization of seleno-glutathione peroxidase in the adult mouse brain.

  1996cites this paper
• 8OHdG levels in brain do not indicate oxidative DNA damage in Alzheimer's disease.

  1996cites this paper
• Oxidative stress in Parkinson's disease and other neurodegenerative disorders.

  1996cites this paper
• Amyloid β Protein Primes Cultured Rat Microglial Cells for an Enhanced Phorbol 12‐Myristate 13‐Acetate‐Induced Respiratory Burst Activity

  1996cites this paper
• The Significance of Glucose Turnover in the Brain in the Pathogenetic Mechanisms of Alzheimer's Disease

  1996cites this paper
• Cholinergic Stimulation of AP-1 and NFκB Transcription Factors Is Differentially Sensitive to Oxidative Stress in SH-SY5Y Neuroblastoma: Relationship to Phosphoinositide Hydrolysis

  1996cites this paper
• Different amyloidogenic peptides share a similar mechanism of neurotoxicity involving reactive oxygen species and calcium.

  1995cites this paper
• Down's syndrome and the links with Alzheimer's disease.

  1995cites this paper
• Oxidative stress and Alzheimer's disease.

  1995cites this paper
• The toxicity in vitro of beta-amyloid protein.

  1995cites this paper
• Future Therapeutic Developments of Estrogen Use

  1995cites this paper
• Oxygen radical metabolism in vivo: molecular genetic models and assays.

  1994cites this paper
• Oxygen-free radicals and amyloidosis in Alzheimer's disease: is there a connection?

  1994cites this paper
• In Vivo Protective Effects of Ferulic Acid Ethyl Ester against Amyloid-beta Peptide 1–42-induced Oxidative Stress

  year unknowncites this paper